Evident
Evident Corporation is a scientific imaging company spun off from Olympus in 2022 that provides AI-driven imaging technologies, digital pathology solutions, and whole slide imaging systems to hospitals, research facilities, and educational institutions globally.
- Company typePrivate
- Founded2022
- HeadquartersMobile, United States
- Headcount1,001–5,000
- GTM typeB2B
- OfferingHardware or Manufacturing
What Evident does
Evident Corporation is a scientific imaging company that was spun off from Olympus Corporation in 2022 as an independent entity. The company develops and markets AI-driven imaging technologies—including whole slide imaging, digital pathology solutions, and autonomous scanning systems—for hospitals, research facilities, and educational institutions globally.
Following a major corporate restructuring in January 2025, when Evident sold its Inspection Technologies division to Wabtec Corp. for $1.78 billion (a unit expected to generate approximately $433 million in 2024 revenue), the company has refocused on its scientific imaging and digital pathology portfolio. In August 2025, Evident announced the acquisition of Pramana, a manufacturer of whole slide imaging and digital pathology solutions whose autonomous scanning systems use volumetric imaging and real-time AI algorithms to eliminate up to 70% of manual workflow steps while capturing previously undetectable tissue features.
Evident operates primarily through direct enterprise sales to institutional buyers, with a recurring/subscription-style revenue model on imaging technology deployments. The company also runs an annual "Image of the Year" award program that draws microscopic imaging submissions from approximately 34 countries, providing a global brand-building and customer-engagement channel. The firmographics block in the source data conflicts with this profile (describing an EHR/data analytics company for rural hospitals in Mobile, AL, founded in 2015) and is treated as low-confidence because it lacks corroborating source IDs and conflicts with multiple detailed sourced data points.
Evident firmographics
Firmographics- Name
- Evident
- Legal name
- Evident Corporation
- Website
- https://evident.com
- Company type
- Private
- Founded year
- 2022
- Operating status
- Operating
- Headcount range
- 1,001–5,000 employees
- Short description
- Evident Corporation is a scientific imaging company spun off from Olympus in 2022 that provides AI-driven imaging technologies, digital pathology solutions, and whole slide imaging systems to hospitals, research facilities, and educational institutions globally.
- Ownership category
- akta.pro rank
Evident industry classification
Industry- Product category
- Scientific Imaging Equipment
- NAICS
- Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451)
- SIC
- Laboratory Analytical Instruments (3826)
- akta.pro primary industry
- Medical Imaging AI (HDAAAEAH)
- akta.pro secondary industries
- Universal Viewers & Enterprise Imaging Access (Zero-footprint/Diagnostic) (HLACALAD), Radiology AI, CAD & Advanced Visualization Software (HLAHABAJ), Imaging Interoperability & Standards Enablement (DICOM/HL7/FHIR/IHE) (HLACALAJ)
Keywords
Where Evident is headquartered
LocationHeadquarters
- HQ city
- Mobile
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Evident business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Supply Chain, Marketing or Sales, Operations
Revenue model
- AI-driven Imaging Technologies: Evident generates revenue through AI-driven imaging technologies and solutions for hospitals, research facilities, and educational institutions, including digital pathology solutions and whole slide imaging technologies acquired through the Pramana acquisition.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels1 record
Evident product offering
Product offeringCore offering
Evident Corporation is a scientific imaging company that develops and sells AI-driven imaging technologies, including whole slide imaging systems and digital pathology solutions. The company serves hospitals, research facilities, and educational institutions with autonomous scanning systems that use volumetric imaging and real-time AI algorithms to capture tissue features and reduce manual workflow steps.
Product overview
Evident is a scientific imaging company spun off from Olympus Corporation in 2022, focused on AI-driven imaging technologies. The company expanded its portfolio through the acquisition of Pramana (2025), a manufacturer of whole slide imaging and digital pathology solutions. Evident also operates an annual Image of the Year Award program recognizing outstanding scientific microscopic imaging submissions from around the world.
Differentiator
Problem solved
Functional benefit
Products and services
- Pramana Whole Slide Imaging Systems
- Autonomous Scanning Systems
Quantifiable outcome
- Up to 70% reduction in manual workflow steps through autonomous scanning systems
Companies that use Evident
Customer profileNamed customers3 records
Segments1 record
Ideal customer profiles1 record
Evident technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability3 records
Feature1 record
Evident partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- PramanacoreEvident acquired Pramana, a manufacturer of whole slide imaging technologies and digital pathology solutions founded in 2021. Pramana's autonomous scanning systems use volumetric imaging and real-time AI algorithms that can eliminate up to 70% of manual workflow steps while capturing previously undetectable tissue features. The acquisition expanded Evident's portfolio of AI-driven imaging technologies for hospitals, research facilities, and educational institutions. Deal terms were not disclosed.
Scale indicators3 records
Recent moves6 records
Expansion highlights4 records
Evident competitors and assessment
Company assessmentDirect peers
- Nikon Instruments: Nikon competes with Evident in advanced light microscopy and digital pathology imaging for research and clinical customers, with comparable enterprise sales motion into hospitals and academic medical centers.
- 3DHISTECH: 3DHISTECH is a digital pathology scanner and workflow vendor with a P1000 slide scanner and integrated pathology software suite, directly comparable to Evident/Pramana's whole slide imaging offerings.
- Hamamatsu Photonics: Hamamatsu's NanoZoomer line is one of the most widely deployed whole slide imaging scanners globally, competing directly with Pramana's autonomous scanning systems in research and clinical pathology labs.
- Carl Zeiss Microscopy: Zeiss is a leading microscopy and imaging systems provider serving the same research, academic, and clinical imaging customers as Evident, with overlapping product lines in light microscopy and digital imaging platforms.
- Leica Biosystems: Leica Biosystems (a Danaher operating company) is a direct competitor in digital pathology and whole slide imaging, offering the Aperio GT 450 scanner and a broad clinical pathology workflow portfolio that overlaps directly with Evident/Pramana's offerings.
- Roche (Ventana Digital Pathology): Roche's Ventana digital pathology portfolio (including the DP 600 scanner and Roche Digital Pathology workflow) competes with Evident/Pramana in clinical anatomic pathology labs, particularly integrated with Roche's companion diagnostics business.
Emerging players
- Visiopharm: Visiopharm provides AI-driven image analysis and workflow software for digital pathology, complementary to scanner hardware and overlapping with the AI-powered workflow value proposition that Pramana brings to Evident.
- Indica Labs: Indica Labs offers AI-based digital pathology image analysis software (HALO platform) used by pharma, research, and clinical customers, sitting adjacent to Evident/Pramana's hardware-software pathology stack.
- Motic Digital Pathology: Motic offers digital pathology slide scanners and microscopy solutions serving research and clinical pathology customers, with comparable enterprise targeting and price points to Pramana's autonomous scanning systems.
Broad incumbents
- Olympus Corporation: Olympus is Evident's former parent and a broad incumbent in scientific and medical imaging (microscopes, endoscopes, life science), continuing to operate overlapping product lines and serving the same enterprise imaging customer base.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat3 records
Key highlights6 records
Customer concentration
Evident social profiles
Digital presenceEvident financial estimates
Financial estimateRevenue estimate
Valuation estimate
Evident leadership team
Management profileNumber of profiles
Evident subsidiaries and ownership
Company hierarchySubsidiaries1 record
Evident funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Evident M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Evident
What does Evident do?
Evident Corporation is a scientific imaging company that develops and sells AI-driven imaging technologies, including whole slide imaging systems and digital pathology solutions. The company serves hospitals, research facilities, and educational institutions with autonomous scanning systems that use volumetric imaging and real-time AI algorithms to capture tissue features and reduce manual workflow steps.
Is Evident a public or private company?
Evident is a private company. It is classified as corporate owned and is currently operating.
When was Evident founded?
Evident was founded in 2022. It employs 1,001 to 5,000 people.
Where is Evident based?
Evident is headquartered in Mobile, United States, in the North America region.
How does Evident make money?
One revenue line is on record: AI-driven Imaging Technologies.
Who are Evident's main competitors?
Direct peers on record are Nikon Instruments, 3DHISTECH, Hamamatsu Photonics, Carl Zeiss Microscopy, Leica Biosystems and Roche (Ventana Digital Pathology). Emerging players are Visiopharm, Indica Labs and Motic Digital Pathology. Olympus Corporation is listed as a broad incumbent.
Does Evident have an API?
No public API is recorded for Evident.
What industry is Evident in?
Evident's product category is Scientific Imaging Equipment. Its primary akta.pro industry code is HDAAAEAH, Medical Imaging AI, with a secondary code of HLACALAD, Universal Viewers & Enterprise Imaging Access (Zero-footprint/Diagnostic). Its NAICS code is 33451 and its SIC code is 3826.